Itraconazole pulse therapy for onychomycosis and dermatomycoses: An overview

Journal of the American Academy of Dermatology

Volumn 37, Issue 6, 1997, Pages 969-974

  De Doncker, P ^a   Gupta, A K ^a   Marynissen, G ^a   Stoffels, P ^a   Heremans, A ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ABDOMINAL PAIN; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOMYCOSIS; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN TOXICITY; SOMNOLENCE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0031457591     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(97)70074-4     Document Type: Article

References (58)

1. A Espinel-Ingroff S Shadomy RJ. Gebhart In vitro studies with R 51,211 (itraconazole) Antimicrob Agents Chemother 26 1986 5 9
2. G Cauwenbergh H Degreef J Heykants R Woestenborghs P Van Rooy K. Haeverans Pharmacokinetic profile of orally administered itraconazole in human skin J Am Acad Dermatol 18 1988 263 268
3. L Matthieu P De Doncker G Cauwenbergh R Woestenborghs V Van De Velde PAJ. Janssen Itraconazole penetrates the nail via the nail matrix and the nail bed: an investigation in onychomycosis Clin Exp Dermatol 16 1991 374 376
4. P De Doncker J Decroix GE Piérard D Roelant R Woestenborghs P Jacqmin Antifungal pulse therapy for onychomycosis Arch Dermatol 132 1996 34 41
5. M Willemsen P De Doncker J Willems R Woestenborghs V Van De Velde J Heykants Posttreatment itraconazole levels in the nail J Am Acad Dermatol 26 1992 731 735
6. AK Gupta P. De Doncker Itraconazole is effective in the treatment of Majocchi's granuloma [abstract] Australas J Dermatol 38 Suppl, 2 1997 95
7. GE Piérard JE Arrese P. De Doncker Antifungal activity of itraconazole and terbinafine in human stratum corneum: a comparative study J Am Acad Dermatol 32 1995 429 435
8. R DerSimonian NM. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 178
9. V. Velanovich Meta-analysis for combining Bayesian probabilities Med Hypotheses 35 1991 192 195
10. AK Gupta DN Sauder NH. Shear Antifungal agents: an overview. Part II J Am Acad Dermatol 30 1994 911 933
11. J Zurita RJ. Hay Adherence of dermatophyte microconidia and arthroconidia to human keratinocytes in vitro J Invest Dermatol 89 1987 529 534
12. H Degreef K Marien H DeVeylder K Duprez A Borghys L. Verhoeye Itraconazole in the treatment of dermatophytoses: a comparison of two daily dosages Rev Infect Dis 9 1987 S104 S108
13. G Cauwenbergh P. De Doncker The clinical use of itraconazole in superficial and deep mycoses RA Fromtling Recent trends in the discovery, development, and evaluation of antifungal agents. 1987 J.R. Prous Science Publishers Barcelona 273 284
14. E Van Hecke J. Van Cutsem Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manuum Mycoses 31 1988 641 649
15. D Roseeuw M Willemsen RT Kint W Peremans RLJ Mertens J. Van Cutsem Itraconazole in the treatment of superficial mycoses: a double-blind study vs placebo Clin Exp Dermatol 15 1990 101 104
16. A Saul A. Bonifaz Itraconazole in common dermatophyte infections of the skin: fixed treatment schedules J Am Acad Dermatol 23 1990 554 558
17. EM Difonzo E Panconesi P. Cilli Itraconazole in dermatophyte infections: clinical experience in Italy Proc Symp Fungal Infections in the Nineties 44 1990 115 117
18. RJ Hay YM Clayton MK Moore G. Midgely Itraconazole in the management of chronic dermatophytosis J Am Acad Dermatol 23 1990 561 564
19. JM. Wishart A double blind study of itraconazole vs griseofulvin in patients with tinea pedis and tinea manus N Z Med J 107 1994 126 128
20. T Rakosi M. Gerber Treatment of tinea with itraconazole: an open multicentre study J Dermatol Treat 6 1995 35 38
21. J. Decroix Tinea pedis (moccasin-type) treated with itraconazole Int J Dermatol 34 1995 122 124
22. JM Lachapelle P De Doncker D Tennstedt G Cauwenbergh PAJ. Janssen Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile Dermatology 184 1992 45 50
23. AK Gupta P De Doncker A Heremans P Stoffels GE Pierard J Decroix Itraconazole for the treatment of tinea pedis: a dose of 400 mg/day given for 1 week is similar in efficacy to 100 or 200 mg/day given for 2 to 4 weeks J Am Acad Dermatol 36 1997 789 792
24. P De Doncker AK Gupta G Marynissen P Stoffels A. Heremans Itraconazole from head to toe: the one-week approach Poster presented at the Summer Meeting of the American Academy of Dermatology, Orlando, FL 1996; July 24-28
25. RJ. Hay Itraconazole 100 mg capsules for dermatomycosis. Summary of the efficacy and safety of a treatment of 1 week with 200 mg o.d. for tinea corporis/cruris and 200 mg b.i.d. for plantar tinea pedis. Clinical Expert Report N 118783/1 1996 1 29 Janssen Research Foundation, Beerse, Belgium
26. STM Nuijten JL. Schuller Itraconazole in the treatment of tinea corporis: a pilot study Rev Infect Dis 9 1987 S119 S120
27. D Panagiotidou T Kousidou G Chaidemenos G Karakatsanis A Kalogeropoulou A Teknetzis A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study J Int Med Res 20 1992 392 400
28. A Katsambas CH Antoniou E Frangouli D Rigopoulos M Vlachou D Michailidis Itraconazole in the treatment of tinea corporis and tinea cruris Clin Exp Dermatol 18 1993 322 325
29. A Bourlond JM Lachapelle J Aussems B Boyden H Campaert J Decroix Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris Int J Dermatol 28 1989 410 412
30. DM Pariser RJ Pariser G Ruoff TL. Ray Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea cruris J Am Acad Dermatol 31 1994 232 234
31. D Parent J Decroix M. Heenen Clinical experience with short schedules of itraconazole in the treatment of tinea corporis and/or tinea cruris Dermatology 189 1994 378 381
32. RA. Estrada Itraconazole in pityriasis versicolor Rev Infect Dis 9 1987 S128 S130
33. ADP Hernanz SD Vicente FM Ramas ARN. Belaustegui Randomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis versicolor Rev Infect Dis 9 1987 S121 S127
34. E Panconesi E. Difonzo Treatment of dermatophytoses and pityriasis versicolor with itraconazole Rev Infect Dis 9 1987 S109 S113
35. Terbinafine for dermatophytes in skin and nail Drug Ther Bull 30 1992 47 48
36. J. Delescluse Itraconazole in tinea versicolor: a review J Am Acad Dermatol 23 1990 551 554
37. P De Doncker AK Gupta A Heremans P Stoffels J. Delescluse Itraconazole in tinea versicolor: a review Poster presented at the 54th Annual Meeting of the American Academy of Dermatology, Washington, D.C 1996;Feb 10 15
38. J Van Cutsem F Van Gerven PAJ. Janssen The in vitro and in vivo antifungal activity of itraconazole RA Fromtling Recent trends in the discovery, development and evaluation of antifungal agents. 1987 JR Prous Science Publishers Barcelona 177 192
39. J. Faergemann Treatment of pityriasis versicolor with itraconazole: a double-blind placebo controlled study Mycoses 31 1988 377 379
40. J Delescluse G Cauwenbergh H. Degreef Itraconazole, a new orally active antifungal, in the treatment of pityriasis versicolor Br J Dermatol 114 1986 701 703
41. RL Galimberti I Villalba S Galarza A Raimondi V. Flores Itraconazole in pityriasis versicolor: ultrastructural changes in Malassezia furfur produced during treatment Rev Infect Dis 9 Suppl 1987 S134 S138
42. G Cauwenbergh P De Doncker K Stoops AM De Dier H Goyvaerts V. Schuermans Itraconazole in the treatment of human mycoses: review of three years of clinical experience Rev Infect Dis 9 1987 S146 S152
43. P De Doncker J Van Lint P Dockx D. Roseeuw Pulse therapy with one-week itraconazole monthly for three or four months in the treatment of onychomycosis Cutis 56 1995 180 183
44. V Havu H Brandt H Heikkila A Hollmen R Oksman T Rantanen A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toenail onychomycosis Br J Dermatol 136 1997 230 234
45. A. Heremans Clinical expert summary on itraconazole for the treatment of onychomycosis with a shortened regime of 200 mg b.i.d. × 7 days/month for 2 or 3 months Janssen Clinical Research Report N 111629M. 1995 1 44
46. J André P De Doncker G Ginter R Wang P Stoffels A Heremans Intermittent pulse therapy with itraconazole in onychomycosis: an update Poster presented at the 54th Annual Meeting of the American Academy of Dermatology, Washington, D.C 1996;Feb 10 15
47. E Haneke J Ring D Tajerbashi D De Doncker A. Heremans Efficacy and safety of itraconazole 1-week pulse therapy in the treatment of onychomycosis: an open German multicenter trial Poster presented at the 54th Annual Meeting of the American Academy of Dermatology, Washington, D.C 1996;Feb 10 15
48. WD Li WA Ping LR Yu R Wang D De Doncker A. Heremans Therapeutic efficacy of intermittent pulse therapy with itraconazole in onychomycosis: a Chinese multicenter trial Poster presented at the 54th Annual Meeting of the American Academy of Dermatology, Washington, D.C 1996;Feb 10 15
49. A Tosti BM Piraccini C Stinchi N Venturo B Federico M. Colombo Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy J Am Acad Dermatol 34 1996 595 600
50. Gupta AK, De Doncker P, Scher RK, Haneke E, Daniel CR, Andre J, et al. Itraconazole for the treatment of onychomycosis: an overview. Int J Dermatol In press.
51. RJ Hay YM Clayton MK Moore G. Midgely An evaluation of itraconazole in the management of onychomycosis Br J Dermatol 119 1988 359 366
52. S. Kagawa A clinical evaluation of itraconazole, a new oral antifungal agent, in the treatment of tinea unguium, candida onychomycosis, and candida onychia/paronychia The Clinical Report 25 1991 433 448
53. A Tosti BM Piraccini C Vincenzi N. Cameli Itraconazole in the treatment of chronic mucocutaneous candidiasis in childhood Poster presented at the 54th Annual Meeting of the American Academy of Dermatology, Washington, D.C Feb. 10-15, 1996
54. A Rashid P. De Doncker Pulse-dose regimen of oral itraconazole in the treatment of Candida paronychia International Summit on Cutaneous Antifungal Therapy Programme. Vancouver, B.C., Canada 1996;May 26-28 Abstract 55
55. PRG De Doncker RK Scher RL Baran J Decroix HJ Degreef DI Roseeuw Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients J Am Acad Dermatol 36 1997 173 177
56. A Tosti BM Piraccini C Stinchi S. Lorenzi Onychomycosis due to Scopulariopsis brevicaulis : clinical features and response to systemic antifungals Br J Dermatol 135 1996 799 802
57. Itraconazole International Product Monograph 1996 Beerse, Belgium 1 7
58. Itraconazole Product Monograph (United States) 1996 Janssen Pharmaceutica Titusville (NJ)